Effectiveness
Effectiveness
In studies, cell therapy decreased pain or disability more than 50% in multiple orthopedic conditions. Doctors use cell therapy in a variety of conditions related to connective tissue and/or inflammation:
Cell therapy results depend on several factors including the type of therapy, the severity of the condition and patient characteristics. A cell therapy or regenerative medicine doctor can help patients understand what this type of treatment may do for their individual case.
Published medical studies can provide an idea of the cell therapy results some patients have experienced. In studies, autologous cell therapy has done the following:
Centrifugation allows the MSCs, platelets and immune cells to gather in the collection area. After centrifugation, the specialist removes the fluid in the collection area. This fluid is bone marrow concentrate (BMC). Bone marrow concentrate contains clinically effective numbers of MSCs and other cells in a small volume. This means doctors can take these powerful cells and place them in smaller areas, such as knee joints or shoulder tendons.
Most autologous cell therapies in the United States use bone marrow concentrate. Doctors prefer it over other therapies due to its accessibility, safety and efficacy.
NOTE: Many PRP devices and systems exist, but they do not all achieve the same end product. Some start with such a small volume of blood that it is impossible for them to turn out an effective PRP. Others lose nearly 50% of platelets during processing.
This is wasteful and doesn’t give patients the best chance of a good outcome. The NextGen PRP system provides high platelet recovery and is the only PRP system with optional in-line ultrafiltration of plasma proteins. This makes it the most versatile and powerful PRP system in the world.